[HTML][HTML] COVID-19 vaccines

D Ndwandwe, CS Wiysonge - Current opinion in immunology, 2021 - Elsevier
Highlights•COVID-19 vaccine development has accelerated at an incredible rate with 105
vaccines in clinical development and 18 approved for emergency use.•This is the first time in …

The COVID-19 vaccines: recent development, challenges and prospects

Y Yan, Y Pang, Z Lyu, R Wang, X Wu, C You, H Zhao… - Vaccines, 2021 - mdpi.com
The highly infectious coronavirus disease 2019 (COVID-19) associated with the pathogenic
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread to become a …

COVID-19 vaccines: breaking record times to first-in-human trials

YC Kim, B Dema, A Reyes-Sandoval - npj Vaccines, 2020 - nature.com
COVID-19 vaccines: breaking record times to first-in-human trials | npj Vaccines Skip to main
content Thank you for visiting nature.com. You are using a browser version with limited support …

A narrative review of COVID-19 vaccines

B Eroglu, RF Nuwarda, I Ramzan, V Kayser - Vaccines, 2021 - mdpi.com
The COVID-19 pandemic has shaken the world since early 2020 and its health, social,
economic, and societal negative impacts at the global scale have been catastrophic. Since …

A COVID-19 vaccine: big strides come with big challenges

J Mellet, MS Pepper - Vaccines, 2021 - mdpi.com
As of 8 January 2021, there were 86,749,940 confirmed coronavirus disease 2019 (COVID-
19) cases and 1,890,342 COVID-19-related deaths worldwide, as reported by the World …

COVID-19 vaccine: where are we now and where should we go?

S Soleimanpour, A Yaghoubi - Expert review of vaccines, 2021 - Taylor & Francis
Introduction The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has
currently caused the pandemic with a high progressive speed and has been considered as …

COVID-19 vaccines: current understanding on immunogenicity, safety, and further considerations

Q He, Q Mao, J Zhang, L Bian, F Gao, J Wang… - Frontiers in …, 2021 - frontiersin.org
The world has entered the second wave of the COVID-19 pandemic, and its intensity is
significantly higher than that of the first wave of early 2020. Many countries or regions have …

COVID-19 vaccines: concerns beyond protective efficacy and safety

CC Lai, IT Chen, CM Chao, PI Lee, WC Ko… - Expert review of …, 2021 - Taylor & Francis
Introduction Several vaccine candidates have been developed using different platforms,
including nucleic acids (DNA and RNA), viral vectors (replicating and non-replicating), virus …

Efforts at COVID-19 vaccine development: challenges and successes

A Haque, AB Pant - Vaccines, 2020 - mdpi.com
The rapid spread of SARS-CoV-2, the new coronavirus (CoV), throughout the globe poses a
daunting public health emergency. Different preventive efforts have been undertaken in …

COVID-19 vaccines: rapid development, implications, challenges and future prospects

S Kashte, A Gulbake, SF El-Amin III, A Gupta - Human cell, 2021 - Springer
COVID-19 has affected millions of people and put an unparalleled burden on healthcare
systems as well as economies throughout the world. Currently, there is no decisive therapy …